These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37406007)

  • 1. DAPTEV: Deep aptamer evolutionary modelling for COVID-19 drug design.
    Andress C; Kappel K; Villena ME; Cuperlovic-Culf M; Yan H; Li Y
    PLoS Comput Biol; 2023 Jul; 19(7):e1010774. PubMed ID: 37406007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].
    Han S; Zhao L; Yang G; Qu F
    Se Pu; 2021 Jul; 39(7):721-729. PubMed ID: 34227370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence in Aptamer-Target Binding Prediction.
    Chen Z; Hu L; Zhang BT; Lu A; Wang Y; Yu Y; Zhang G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Design for the Fixed Primer Regions in an Oligonucleotide Library for SELEX Aptamer Screening.
    Wang B
    Front Chem; 2020; 8():475. PubMed ID: 32582641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primer-free aptamer selection using a random DNA library.
    Pan W; Xin P; Patrick S; Dean S; Keating C; Clawson G
    J Vis Exp; 2010 Jul; (41):. PubMed ID: 20689511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Prediction of Aptamers Assisted by In Silico Methods.
    Lee SJ; Cho J; Lee BH; Hwang D; Park JW
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of DNA aptamers specific for small therapeutic peptides using a modified SELEX method.
    Lee J; Ryu M; Bae D; Kim HM; Eyun SI; Bae J; Lee K
    J Microbiol; 2022 Jul; 60(7):659-667. PubMed ID: 35731347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of Novel Aptamers Specific for Human PD1 Using Hybrid Systematic Evolution of Ligands by Exponential Enrichment Approach.
    Khedri M; Abnous K; Rafatpanah H; Nabavinia MS; Taghdisi SM; Ramezani M
    Immunol Invest; 2020 Jul; 49(5):535-554. PubMed ID: 32429721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating aptamers by cell-SELEX for applications in molecular medicine.
    Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
    Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application.
    Gan Z; Roslan MAM; Abd Shukor MY; Halim M; Yasid NA; Abdullah J; Md Yasin IS; Wasoh H
    Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RaptRanker: in silico RNA aptamer selection from HT-SELEX experiment based on local sequence and structure information.
    Ishida R; Adachi T; Yokota A; Yoshihara H; Aoki K; Nakamura Y; Hamada M
    Nucleic Acids Res; 2020 Aug; 48(14):e82. PubMed ID: 32537639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating Post-SELEX Aptamer Engineering Using Exonuclease Digestion.
    Canoura J; Yu H; Alkhamis O; Roncancio D; Farhana R; Xiao Y
    J Am Chem Soc; 2021 Jan; 143(2):805-816. PubMed ID: 33378616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
    Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
    Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational predictive approaches for interaction and structure of aptamers.
    Emami N; Pakchin PS; Ferdousi R
    J Theor Biol; 2020 Jul; 497():110268. PubMed ID: 32311376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.